Annual CFI
$4.96 M
+$5.23 M+1916.65%
June 30, 2024
Summary
- As of February 10, 2025, ESLAW annual cash flow from investing activities is $4.96 million, with the most recent change of +$5.23 million (+1916.65%) on June 30, 2024.
Performance
ESLAW Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 10, 2025, ESLAW quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, ESLAW quarterly CFI has dropped by -$5.07 million (-100.00%).
Performance
ESLAW Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$5.07 M
+$112.30 K+2.26%
September 30, 2024
Summary
- As of February 10, 2025, ESLAW TTM cash flow from investing activities is $5.07 million, with the most recent change of +$112.30 thousand (+2.26%) on September 30, 2024.
- Over the past year, ESLAW TTM CFI has increased by +$112.30 thousand (+2.26%).
Performance
ESLAW TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ESLAW Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1916.7% | -100.0% | +2.3% |
| 3 y3 years | - | -100.0% | +2.3% |
| 5 y5 years | - | -100.0% | +2.3% |
ESLAW Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -105.5% | -100.0% | <-9999.0% | at high | -102.2% |
| 5 y | 5-year | at high | -105.5% | -100.0% | <-9999.0% | at high | -102.2% |
| alltime | all time | at high | -105.5% | -100.0% | <-9999.0% | at high | -102.2% |
Estrella Immunopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $5.07 M(+2.3%) |
| Jun 2024 | $4.96 M | $0.00(0.0%) | $4.96 M(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) | $4.96 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | $5.07 M(-4617.4%) | $4.96 M(-4517.4%) |
| Sep 2023 | - | -$112.30 K(<-9900.0%) | -$112.30 K(<-9900.0%) |
| Jun 2023 | -$273.07 K | - | - |
| Dec 2022 | - | $0.00 | $0.00 |
FAQ
- What is Estrella Immunopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Estrella Immunopharma?
- What is Estrella Immunopharma annual CFI year-on-year change?
- What is Estrella Immunopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly CFI year-on-year change?
- What is Estrella Immunopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Estrella Immunopharma?
- What is Estrella Immunopharma TTM CFI year-on-year change?
What is Estrella Immunopharma annual cash flow from investing activities?
The current annual CFI of ESLAW is $4.96 M
What is the all time high annual CFI for Estrella Immunopharma?
Estrella Immunopharma all-time high annual cash flow from investing activities is $4.96 M
What is Estrella Immunopharma annual CFI year-on-year change?
Over the past year, ESLAW annual cash flow from investing activities has changed by +$5.23 M (+1916.65%)
What is Estrella Immunopharma quarterly cash flow from investing activities?
The current quarterly CFI of ESLAW is $0.00
What is the all time high quarterly CFI for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly cash flow from investing activities is $5.07 M
What is Estrella Immunopharma quarterly CFI year-on-year change?
Over the past year, ESLAW quarterly cash flow from investing activities has changed by -$5.07 M (-100.00%)
What is Estrella Immunopharma TTM cash flow from investing activities?
The current TTM CFI of ESLAW is $5.07 M
What is the all time high TTM CFI for Estrella Immunopharma?
Estrella Immunopharma all-time high TTM cash flow from investing activities is $5.07 M
What is Estrella Immunopharma TTM CFI year-on-year change?
Over the past year, ESLAW TTM cash flow from investing activities has changed by +$112.30 K (+2.26%)